Technical Analysis for CDNA - CareDx, Inc.

Grade Last Price % Change Price Change
grade A 37.27 0.95% 0.35
CDNA closed up 0.95 percent on Monday, March 25, 2019, on 54 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CDNA trend table...

Date Alert Name Type % Chg
Mar 25 Slingshot Bullish Bullish Swing Setup 0.00%
Mar 25 Wide Bands Range Expansion 0.00%
Mar 25 Overbought Stochastic Strength 0.00%
Mar 22 Slingshot Bullish Bullish Swing Setup 0.95%
Mar 22 New 52 Week High Strength 0.95%
Mar 22 Outside Day Range Expansion 0.95%
Mar 22 Wide Bands Range Expansion 0.95%
Mar 22 Overbought Stochastic Strength 0.95%
Mar 21 New 52 Week Closing High Bullish -4.95%
Mar 21 New 52 Week High Strength -4.95%

Older signals for CDNA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.
Medicine Medical Specialties Clinical Medicine Gene Expression Organ Transplantation Transplantation Medicine
Is CDNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.38
52 Week Low 7.5
Average Volume 787,403
200-Day Moving Average 23.4074
50-Day Moving Average 29.2908
20-Day Moving Average 34.489
10-Day Moving Average 36.936
Average True Range 1.9662
ADX 44.68
+DI 29.7997
-DI 9.3936
Chandelier Exit (Long, 3 ATRs ) 33.4814
Chandelier Exit (Short, 3 ATRs ) 33.8986
Upper Bollinger Band 40.1162
Lower Bollinger Band 28.8618
Percent B (%b) 0.75
BandWidth 32.631854
MACD Line 2.531
MACD Signal Line 2.4861
MACD Histogram 0.0449
Fundamentals Value
Market Cap 840.09 Million
Num Shares 22.5 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -26.81
Price-to-Sales 2.74
Price-to-Book 10.33
PEG Ratio -0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.09
Resistance 3 (R3) 40.11 39.20 39.62
Resistance 2 (R2) 39.20 38.48 39.19 39.46
Resistance 1 (R1) 38.23 38.03 38.72 38.21 39.31
Pivot Point 37.32 37.32 37.56 37.31 37.32
Support 1 (S1) 36.35 36.60 36.84 36.33 35.23
Support 2 (S2) 35.44 36.15 35.43 35.08
Support 3 (S3) 34.47 35.44 34.92
Support 4 (S4) 34.45